Multi-level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian Cancer

Cell
Fabian CosciaMarion Curtis

Abstract

Most high-grade serous ovarian cancer (HGSOC) patients develop resistance to platinum-based chemotherapy and recur, but 15% remain disease free over a decade. To discover drivers of long-term survival, we quantitatively analyzed the proteomes of platinum-resistant and -sensitive HGSOC patients from minute amounts of formalin-fixed, paraffin-embedded tumors. This revealed cancer/testis antigen 45 (CT45) as an independent prognostic factor associated with a doubling of disease-free survival in advanced-stage HGSOC. Phospho- and interaction proteomics tied CT45 to DNA damage pathways through direct interaction with the PP4 phosphatase complex. In vitro, CT45 regulated PP4 activity, and its high expression led to increased DNA damage and platinum sensitivity. CT45-derived HLA class I peptides, identified by immunopeptidomics, activate patient-derived cytotoxic T cells and promote tumor cell killing. This study highlights the power of clinical cancer proteomics to identify targets for chemo- and immunotherapy and illuminate their biological roles.

Citations

Feb 23, 2019·Proteomics. Clinical Applications·Sophia DollMatthias Mann
May 11, 2019·Expert Review of Molecular Diagnostics·Ben Davidson
Jun 8, 2019·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Qiupeng ZhengShenglin Huang
Jan 18, 2020·International Journal of Molecular Sciences·Rebecca C AbbottMisty R Jenkins
May 21, 2020·Current Protocols in Immunology·Meagan R RollinsIngunn M Stromnes
Mar 11, 2020·The Journal of Pathology·Fabian CosciaMatthias Mann
Feb 6, 2020·Journal of Lasers in Medical Sciences·Shabnam ShahrokhMohammadreza Razzaghi
Aug 2, 2019·Nature·Zhonghao JiangZhen-Ming Pei
Jun 4, 2020·Clinical Proteomics·Andrew MacklinThomas Kislinger
Sep 23, 2020·International Journal of Molecular Sciences·Maria Hernandez-ValladaresFrode Selheim
Oct 11, 2020·Journal of Hematology & Oncology·Meinusha GovindarajanThomas Kislinger
Dec 17, 2020·Journal of Gynecologic Oncology·Hsiao Yun LuWen Fang Cheng
Mar 7, 2021·Journal of Personalized Medicine·Christen A KhellaMichael L Gatza
Mar 4, 2021·Cell Reports·Gali Yanovich-AradTamar Geiger
Apr 21, 2021·Expert Review of Proteomics·Olson Tsang, Jason W H Wong
Oct 22, 2020·Cell Reports·Yingwei HuUNKNOWN Clinical Proteomic Tumor Analysis Consortium
May 3, 2021·Biochimica Et Biophysica Acta. Reviews on Cancer·Ping YangQuansheng Zhou
Jun 3, 2021·Cancers·Miao SuEdouard C Nice
Jun 29, 2021·Advanced Drug Delivery Reviews·Qi XiaoTiannan Guo
Oct 8, 2021·Molecular Cancer Research : MCR·Benjamin SteinhartJulia Wrobel
Sep 16, 2020·Seminars in Cancer Biology·Olivia Le SauxS Intidhar Labidi-Galy

❮ Previous
Next ❯

Related Concepts

Related Feeds

CZI Human Cell Atlas Seed Network

The aim of the Human Cell Atlas (HCA) is to build reference maps of all human cells in order to enhance our understanding of health and disease. The Seed Networks for the HCA project aims to bring together collaborators with different areas of expertise in order to facilitate the development of the HCA. Find the latest research from members of the HCA Seed Networks here.

Cell eTOC

Cell is a scientific journal publishing research across a broad range of disciplines within the life sciences field. Discover the latest research from Cell here.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.